New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For BMY;PMFG;FB From The Last 14 Days
Check below for free stories on BMY;PMFG;FB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
May 17, 2013
13:21 EDTBMYOptions with increasing implied volatility: CPRT BMY GDI HNZ
Subscribe for More Information
06:51 EDTFBFacebook volatility at low end of historic range
Subscribe for More Information
06:36 EDTFBGoogle to add new apps to Google Glass, NY Times says
Subscribe for More Information
May 16, 2013
16:32 EDTBMYBristol-Myers announces intention to voluntarily delist preferred stock
Subscribe for More Information
13:20 EDTBMYFollow-up: Bristol-Myers upgraded to Outperform from Market Perform at Leerink
Leerink upgraded Bristol-Myers citing the company's multi-billion dollar immuno-oncology prospects. The firm says there were additional responses reported in the press briefing with combination nivolumab and Yervoy. Leerink has a $51 price target for shares.
13:14 EDTBMYBristol-Myers upgraded to Outperform from Market Perform at Leerink
Subscribe for More Information
08:55 EDTBMYBofA/Merrill's pharmaceuticals analysts hold analyst/industry conference call
Subscribe for More Information
08:38 EDTBMYBristol-Myers shares likely to give back recent gains, says Leerink
Leerink expects shares of Bristol-Myers to give back recent gains after ASCO published abstracts last night. The firm found the abstracts as in-line with, but not above, its expectations for nivolumab alone or immuno-oncology combination therapy and keeps a Market Perform rating on Bristol-Myers.
05:59 EDTFBHigh tech firms involved in immigration battle, WSJ reports
Subscribe for More Information
05:57 EDTFBFacebook implied volatility at lower end of index mean range
Subscribe for More Information
05:52 EDTBMYStocks with implied volatility movement; BMY SLV
Subscribe for More Information
May 15, 2013
17:46 EDTFBSAC Capital gives quarterly update on stakes
NEW STAKES: Discovery (DISCA), Liberty Global (LBTYA), Liberty Media (LMCA), Norwegian Cruise Line (NCLH), and Cubist (CBST). INCREASED STAKES: Suncor (SU), EQT Corporation (EQT), Amazon.com (AMZN), Visa (V), and GNC Holdings (GNC). DECREASED STAKES: News Corp. (NWSA), Facebook (FB), Sherwin-Williams (SHW), and Avago (AVGO). LIQUIDATED STAKES: Coach (COH), Dover (DOV), and Virgin Media (VMED), .
11:28 EDTBMYOptions with increasing implied volatility: BMY AGNC EBIX IAU
Subscribe for More Information
09:43 EDTBMYActive equity option families trading on open
Subscribe for More Information
05:59 EDTFBCorporate boards recruit newcomers with digital knowledge, WSJ reports
Subscribe for More Information
May 14, 2013
17:48 EDTFBLone Pine gives quarterly update on stakes
NEW STAKES: Valeant Pharmaceuticals (VRX), Virgin Media (VMED), Thermo Fisher Scientific (TMO), CME Group (CME), and Liberty Media (LMCA). INCREASED STAKES: Mead Johnson Nutrition (MJN), News Corp (NWSA), Intuitive Surgical (ISRG), Monsanto (MON), and Qualcomm (QCOM). DECREASED STAKES: Cognizant Technology Solutions (CTSH), Equinix (EQIX), Ralph Lauren (RL), Disney (DIS), and Oceaneering International (OII). LIQUIDATED STAKES: Facebook (FB), Crown Castle (CCI), Accretive Health (AH), Informatica (INFA), and NetEase (NTES).
07:24 EDTBMYEBD Group to host a conference
BioTrinity 2013 is being held in Newbury, England on May 14-16.
06:07 EDTFBAT&T may drop HTC Facebook phone, Bloomberg reports
Subscribe for More Information
05:53 EDTFBWeb browsers are being reinvented, WSJ reports
Subscribe for More Information
May 13, 2013
12:17 EDTFBFacebook's Waze deal hits snag, BGR reports
Facebook's acquisition of social navigation company Waze has hit some complications, said BGR, citing a report from the Israeli newspaper Calcalist. The main area of contention is Facebook's desire to close Waze’s Israel-based R&D center and transfer several employees to the U.S., the report said. Reference Link
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.